Second deal for Bain Capital
The US private equity firm has made its second carve-out acquisition in three days with the E200m purchase of Trespaphan from Celanese.
30 December 2012•1 min read
The US private equity firm has made its second carve-out acquisition in three days with the E200m purchase of Trespaphan from Celanese.
Side Letter: Exits and earnings
9 November 2026 · 3 mins read
Private Take: Reading beyond the scoreboard
9 November 2026 · 4 mins read
PEI Private Equity Awards 2026: Send us your highlights!
5 November 2026 · 6 mins read
Side Letter: Markdowns, moratoriums
5 November 2026 · 2 mins read
AllianzGI leaves door open for reversal of PE pullback
5 November 2026 · 2 mins read
How Schroders’ $30bn PE funds platform is growing its CV and co-invest allocations
5 November 2026 · 4 mins read
Side Letter: Johns, jitters, judgment calls
4 November 2026 · 5 mins read
